I K U
 
 

END ALZHEIMER’S

in the

N e u r o D R O

a decentralized research organization

Research by U.S. NIH, Funded by ALZ Association

Molecules 2.png

NEURODRO LEAD SCIENTISTS

 
Mitch Kling, MD    Harvard Medical School, Professor at University of Pennsylvania, NIH Fellow

Mitch Kling, MD

Harvard Medical School, Professor at University of Pennsylvania, NIH Fellow

 
Dayan Goodenowe, PhD    CEO & Founder Prodrome Science

Dayan Goodenowe, PhD

CEO & Founder Prodrome Science

 
Molecules 2.png

 

THE IKU NEURODRO

The NeuroDRO is IKU’s first DRO to tokenize a scientific breakthrough that may end Alzheimer's Disease. You will need the NEURON Token for access and commercial royalty rights of a supplement addressing a $300 billion annual market. Token economics are coming soon.

SCIENTIFIC JUSTIFICATION

 

 

Why they’re confident this will work

 
 
 
 

HOW IKU’s Neurodro WORKS

 

You own the research

Collaborate and own a stake in the DRO’s r&d where everyone is incentivized to participate in the effort to stop Alzheimer’s and neurodegenerative disease.

 
Research.png
 
 
 
 
License 2.png
 

You own the license

Own exclusive digital research licenses to data generated in the DRO with provenance enforced and accessed on the blockchain.

 
 

You are rewarded

Contributors will be rewarded with NEURONS, the NeuroDRO native asset required to stake, mine research, and earn royalties on contributed work.

 
New Tech2.png
 
 
 
 
 

Register and stake

Provide us your email for the right to stake the NeuroDRO. We need your email for you to claim future NEURON tokens.

 
 
Molecules3.png
 

research supported by

 
 
ALZ ASSOCIATION LOGO.jpg
 
Upenn Logo.png
 
 
 

RESEARCH MADE POSSIBLE BY

 
 

Dayan B Goodenowe, PhD - Prodrome Sciences

Vijitha Senanayake, PhD - Prodrome Sciences

Siamak MahmoudianDehkordi, PhD - Duke University

Matthias Arnold, PhD - Duke University

Tyler Massaro, PhD - Duke University

Alexandra Kueider-Paisley, PhD - Duke University

Jessica D Tenenbaum, PhD - Duke University

Rima Kaddurah-Daouk, Ph.D. - Duke University

Mitchel A Kling, MD - UPENN

Yuk Yee Leung, PhD - UPENN

Li-San Wang, PhD - UPENN

Leslie M Shaw, PhD - UPENN

John Q Trojanowski, MD, PhD - UPENN

Xianlin Han, PhD - University of Texas

Kwangsik Nho, PhD - Indiana University

Rebecca Baillie, PhD - Rosa & Co LLC

 

And